Home>Timeline Stories>Triton Spinoff, Aduro Biotech, Closes Merger with Chinook Therapeutics and Completes $115 Million Private Placement Financing

Combined Company Will Have Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY”

PHOTOS

RELATED MARKETS / VIEW ALL

Portfolio Categories

Triton Spinoff, Aduro Biotech, Closes Merger with Chinook Therapeutics and Completes $115 Million Private Placement Financing

Overview

Combined Company Will Have Over $275 Million in Operating Capital […]

Portfolio Skills

2021

Published On: July 30, 2021

Related Projects

Go to Top